Literature DB >> 18257743

Alterations of cellular redox state during NNK-induced malignant transformation and resistance to radiation.

Yusuke Demizu1, Ryohei Sasaki, Dunyaporn Trachootham, Helene Pelicano, Justin A Colacino, Jinsong Liu, Peng Huang.   

Abstract

Cancer cells often exhibit increased reactive oxygen species generation and altered redox regulation. The current study was conducted to investigate the biochemical and molecular events associated with redox alterations during chemical-induced malignant transformation and to evaluate their potential roles in radiation sensitivity. Immortalized nonmalignant human bronchial epithelial cells were exposed to the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), and a clone of cells exhibiting malignant behaviors was isolated and characterized. This clone initially exhibited an increase in cellular superoxide that eventually decreased after a long-term culture in vitro, associated with altered expression of antioxidant molecules, including an increase in thioredoxin-1 and manganese superoxide dismutase, and a decrease in glutathione peroxidase-1. These cells also showed a significant decrease in sensitivity to ionizing radiation, as demonstrated by less cell death in acute apoptosis analyses and long-term cell proliferation assays. Using biochemical redox modulation and siRNA approach, we showed that the increase in thioredoxin-1 played a significant role in conferring resistance to IR. Although there was a substantial increase in cellular glutathione, inhibition of glutathione synthesis did not increase IR sensitivity. Our study showed complex redox alterations during NNK-induced malignant transformation, and identified Trx-1 as a radiosensitivity modulator.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18257743      PMCID: PMC2717788          DOI: 10.1089/ars.2007.1871

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  31 in total

Review 1.  Peroxiredoxin, a novel family of peroxidases.

Authors:  S G Rhee; S W Kang; T S Chang; W Jeong; K Kim
Journal:  IUBMB Life       Date:  2001-07       Impact factor: 3.885

2.  Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma.

Authors:  Y Soini; K Kahlos; U Näpänkangas; R Kaarteenaho-Wiik; M Säily; P Koistinen; P Pääakkö; A Holmgren; V L Kinnula
Journal:  Clin Cancer Res       Date:  2001-06       Impact factor: 12.531

3.  Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer.

Authors:  S Kakolyris; A Giatromanolaki; M Koukourakis; G Powis; J Souglakos; E Sivridis; V Georgoulias; K C Gatter; A L Harris
Journal:  Clin Cancer Res       Date:  2001-10       Impact factor: 12.531

4.  Lens-specific regulation of the thioredoxin-1 gene, but not thioredoxin-2, upon in vivo photochemical oxidative stress in the Emory mouse.

Authors:  P G Reddy; D K Bhuyan; K C Bhuyan
Journal:  Biochem Biophys Res Commun       Date:  1999-11-19       Impact factor: 3.575

Review 5.  The mitochondrial thioredoxin system.

Authors:  A Miranda-Vizuete; A E Damdimopoulos; G Spyrou
Journal:  Antioxid Redox Signal       Date:  2000       Impact factor: 8.401

6.  Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents.

Authors:  Yan Zhou; Elizabeth O Hileman; William Plunkett; Michael J Keating; Peng Huang
Journal:  Blood       Date:  2003-01-16       Impact factor: 22.113

7.  Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications.

Authors:  J S Carew; Y Zhou; M Albitar; J D Carew; M J Keating; Peng Huang
Journal:  Leukemia       Date:  2003-08       Impact factor: 11.528

8.  Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide.

Authors:  Hongtao Zhao; Shasi Kalivendi; Hao Zhang; Joy Joseph; Kasem Nithipatikom; Jeannette Vásquez-Vivar; B Kalyanaraman
Journal:  Free Radic Biol Med       Date:  2003-06-01       Impact factor: 7.376

9.  Nuclear thioredoxin-1 is required to suppress cisplatin-mediated apoptosis of MCF-7 cells.

Authors:  Xiao-Ping Chen; Shou Liu; Wen-Xin Tang; Zheng-Wang Chen
Journal:  Biochem Biophys Res Commun       Date:  2007-07-18       Impact factor: 3.575

10.  Preferential elevation of Prx I and Trx expression in lung cancer cells following hypoxia and in human lung cancer tissues.

Authors:  H J Kim; H Z Chae; Y J Kim; Y H Kim; T S Hwangs; E M Park; Y M Park
Journal:  Cell Biol Toxicol       Date:  2003-10       Impact factor: 6.691

View more
  8 in total

1.  A LC-MS/MS method for concurrent determination of nicotine metabolites and role of CYP2A6 in nicotine metabolism in U937 macrophages: implications in oxidative stress in HIV + smokers.

Authors:  Mengyao Jin; Ravinder Earla; Ankit Shah; Rajya L Earla; Raeesa Gupte; Ashim K Mitra; Anil Kumar; Santosh Kumar
Journal:  J Neuroimmune Pharmacol       Date:  2011-06-08       Impact factor: 4.147

Review 2.  Nitroxides as cancer imaging agents.

Authors:  Ryan M Davis; James B Mitchell; Murali C Krishna
Journal:  Anticancer Agents Med Chem       Date:  2011-05-01       Impact factor: 2.505

3.  An LC-MS/MS method for concurrent determination of nicotine metabolites and the role of CYP2A6 in nicotine metabolite-mediated oxidative stress in SVGA astrocytes.

Authors:  Anusha Ande; Ravinder Earla; Mengyao Jin; Peter S Silverstein; Ashim K Mitra; Anil Kumar; Santosh Kumar
Journal:  Drug Alcohol Depend       Date:  2012-04-11       Impact factor: 4.492

4.  A bioinformatics filtering strategy for identifying radiation response biomarker candidates.

Authors:  Jung Hun Oh; Harry P Wong; Xiaowei Wang; Joseph O Deasy
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

5.  Effects of redox modulation by inhibition of thioredoxin reductase on radiosensitivity and gene expression.

Authors:  Markus Selenius; Mattias Hedman; David Brodin; Valentina Gandin; Maria Pia Rigobello; Jenny Flygare; Christine Marzano; Alberto Bindoli; Ola Brodin; Mikael Björnstedt; Aristi P Fernandes
Journal:  J Cell Mol Med       Date:  2012-07       Impact factor: 5.310

Review 6.  ADAM17: An Emerging Therapeutic Target for Lung Cancer.

Authors:  Mohamed I Saad; Stefan Rose-John; Brendan J Jenkins
Journal:  Cancers (Basel)       Date:  2019-08-21       Impact factor: 6.639

7.  Anthocyanin Encapsulated Nanoparticles as a Pulmonary Delivery System.

Authors:  Madumani Amararathna; David W Hoskin; H P Vasantha Rupasinghe
Journal:  Oxid Med Cell Longev       Date:  2022-09-10       Impact factor: 7.310

8.  Involvement of p53 mutation and mismatch repair proteins dysregulation in NNK-induced malignant transformation of human bronchial epithelial cells.

Authors:  Ying Shen; Shuilian Zhang; Xiaobin Huang; Kailin Chen; Jing Shen; Zhengyang Wang
Journal:  Biomed Res Int       Date:  2014-08-18       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.